CVS Health — Aug 5, 2026 release

We uniquely enable what our customers want the most: simple, connected and convenient access to affordable, quality healthcare, where, when, and how they want it.”                                                                                                            - David Joyner, CVS Health Chairman and CEO Three Months Ended June 30, Year Ending December 31, In billions, except per share amounts 2026 2025 2026 Projected Total revenues $ 106.1  $ 98.9  At least $414.0 Diluted earnings per share $ 2.31  $ 0.80  $6.84-$7.04 Adjusted EPS (2) $ 2.58  $ 1.81  $7.90-$8.10 Second quarter GAAP diluted EPS of $2.31 increased from $0.80 in the prior year. Adjusted EPS of $2.58 increased from $1.81 in the prior year, primarily due to improved adjusted operating income in the Health Care Benefits segment, reflecting continued execution on the Health Care Benefits segment margin recovery plan. The Company is increasing its full-year 2026 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds. 1 Consolidated second quarter results Three Months Ended June 30, Six Months Ended June 30, In millions, except per share amounts 2026 2025 Change 2026 2025 Change Total revenues $ 106,096  $ 98,915  $ 7,181  $ 206,522  $ 193,503  $ 13,019  Operating income 4,703  2,381  2,322  9,383  5,755  3,628  Adjusted operating income (1) 5,157  3,808  1,349  10,307  8,387  1,920  Net income 2,995  1,013  1,982  5,952  2,795  3,157  Diluted earnings per share $ 2.31  $ 0.80  $ 1.51  $ 4